Sarah A. Richman

928 total citations
14 papers, 702 citations indexed

About

Sarah A. Richman is a scholar working on Oncology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sarah A. Richman has authored 14 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Genetics and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sarah A. Richman's work include CAR-T cell therapy research (10 papers), Virus-based gene therapy research (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Sarah A. Richman is often cited by papers focused on CAR-T cell therapy research (10 papers), Virus-based gene therapy research (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Sarah A. Richman collaborates with scholars based in United States and Taiwan. Sarah A. Richman's co-authors include David M. Kranz, Michael C. Milone, David M. Barrett, Lucy Z. Li, Zachary T. Gershenson, Stephan A. Grupp, Babak Moghimi, Zissimos P. Mourelatos, Selene Nuñez-Cruz and David H. Aggen and has published in prestigious journals such as Blood, The American Journal of Gastroenterology and Molecular Therapy.

In The Last Decade

Sarah A. Richman

14 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah A. Richman United States	12	502	255	220	194	156	14	702
Tatsunori Goto Japan	14	435 0.9×	240 0.9×	216 1.0×	163 0.8×	146 0.9×	48	723
Reona Sakemura United States	13	717 1.4×	261 1.0×	249 1.1×	261 1.3×	227 1.5×	54	879
Caroline Arber United States	16	504 1.0×	343 1.3×	235 1.1×	132 0.7×	164 1.1×	30	762
Ian R. Hardy United States	7	423 0.8×	161 0.6×	185 0.8×	241 1.2×	104 0.7×	10	556
Changzheng Zhang China	6	286 0.6×	166 0.7×	125 0.6×	95 0.5×	71 0.5×	10	483
Stefanie Lesch Germany	8	686 1.4×	278 1.1×	284 1.3×	211 1.1×	188 1.2×	10	798
Elisa Landoni United States	12	625 1.2×	300 1.2×	236 1.1×	253 1.3×	173 1.1×	14	762
Alexandra Kegler Germany	14	494 1.0×	216 0.8×	181 0.8×	273 1.4×	107 0.7×	23	612
S. Burbridge United Kingdom	6	728 1.5×	278 1.1×	209 0.9×	340 1.8×	224 1.4×	9	794
Sanfang Tu China	16	582 1.2×	201 0.8×	297 1.4×	144 0.7×	154 1.0×	52	858

Countries citing papers authored by Sarah A. Richman

Since Specialization

Citations

This map shows the geographic impact of Sarah A. Richman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Richman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Richman more than expected).

Fields of papers citing papers by Sarah A. Richman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Richman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Richman. The network helps show where Sarah A. Richman may publish in the future.

Co-authorship network of co-authors of Sarah A. Richman

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Richman. A scholar is included among the top collaborators of Sarah A. Richman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Richman. Sarah A. Richman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Richman, Sarah A., Liang-Chuan Wang, Edmund K. Moon, et al.. (2020). Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo. Molecular Therapy. 28(7). 1600–1613. 69 indexed citations

Ghassemi, Saba, Francisco J. Martinez-Becerra, Аlyssa M. Master, et al.. (2020). Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design. Molecular Therapy — Methods & Clinical Development. 18. 595–606. 52 indexed citations

Ghassemi, Saba, Francisco J. Martinez-Becerra, Adam Master, et al.. (2020). Novel media formulations to enhance Chimeric Antigen Receptor (CAR) T-cell potency and anti-tumor cell function for adoptive immunotherapy. Cytotherapy. 22(5). S133–S133. 4 indexed citations

Sellmyer, Mark A., Sarah A. Richman, Catherine Hou, et al.. (2019). Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter Gene. Molecular Therapy. 28(1). 42–51. 76 indexed citations

Sellmyer, Mark A., Sarah A. Richman, Catherine Hou, et al.. (2018). In vivo monitoring of CAR T cells using [18F]fluoropropyl-trimethoprim. 59. 122–122. 1 indexed citations

Richman, Sarah A., Selene Nuñez-Cruz, Babak Moghimi, et al.. (2017). High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model. Cancer Immunology Research. 6(1). 36–46. 202 indexed citations

Burke, Carol A., Christina M. Surawicz, Amy S. Oxentenko, et al.. (2017). A National Survey of Burnout in Gastroenterologists: 2017 Naomi Nakao Gender-Based Research Award. The American Journal of Gastroenterology. 112(S1). S593–S594. 11 indexed citations

Zuber, Julien, Brittany Shonts, Ben Sprangers, et al.. (2015). Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD. American Journal of Transplantation. 15(10). 2691–2703. 44 indexed citations

Schmitt, Thomas M., David H. Aggen, Ingunn M. Stromnes, et al.. (2013). Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection. Blood. 122(3). 348–356. 52 indexed citations

10.

Aggen, David H., Adam S. Chervin, Thomas M. Schmitt, et al.. (2011). Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains. Gene Therapy. 19(4). 365–374. 42 indexed citations

11.

Richman, Sarah A., David M. Kranz, & Jennifer D. Stone. (2009). Biosensor Detection Systems: Engineering Stable, High-Affinity Bioreceptors by Yeast Surface Display. Methods in molecular biology. 504. 323–350. 22 indexed citations

12.

Richman, Sarah A., David H. Aggen, Michelle L. Dossett, et al.. (2008). Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain VαVβ fragments. Molecular Immunology. 46(5). 902–916. 47 indexed citations

13.

Richman, Sarah A. & David M. Kranz. (2007). Display, engineering, and applications of antigen-specific T cell receptors. Biomolecular Engineering. 24(4). 361–373. 48 indexed citations

14.

Richman, Sarah A., K. Scott Weber, David L. Donermeyer, et al.. (2006). Development of a novel strategy for engineering high-affinity proteins by yeast display. Protein Engineering Design and Selection. 19(6). 255–264. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact